Glaucoma Surgery Devices Market To Reach $2.27 Billion By 2030

Glaucoma Surgery Devices Market Growth & Trends

The global glaucoma surgery devices market is expected to reach USD 2.27 billion by 2030, registering a CAGR of 4.61% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising global burden of glaucoma is expected to contribute to market growth over the forecast period. In addition, government support, such as favorable reimbursement policies and foreign direct investment provisions, is expected to drive market growth, especially in developing regions. Rising demand for Minimally Invasive Glaucoma Surgery (MIGS) procedures is expected to drive the demand for advanced glaucoma surgery devices over the forecast period.

The government and non-profit organizations have launched several campaigns to raise knowledge about glaucoma and the procedures used to treat it. These efforts are expected to help increase the demand for cutting-edge surgical methods. In addition, a shift in consumer preference toward sophisticated minimally invasive surgical procedures is anticipated to positively affect market expansion. Moreover, the high adoption of surgical treatment over medications for the treatment of glaucoma is expected to boost the market growth in the near future. The traditional way of glaucoma therapy involving topical medications is considered first-line treatment followed by laser surgery.

The development of new procedures, such as MIGS, creates new growth opportunities in the market.According to the National Library of Medicine (NCBI), approximately 40,000 MIGS surgical procedures were performed in patients diagnosed with glaucoma in 2018. This minimally invasive surgery can reduce hospital stays, lowering the chance of patients contracting hospital-acquired infections. Shorter hospital stays also enable patients to return to their normal lives quicker. Frequent launches of advanced devices are also expected to fuel market growth during the forecast period. For instance, in April 2023, Johnson & Johnson Vision received the U.S. FDA 510 (k) clearance for its ELITA Femtosecond laser for the development of LASIK flaps.

 Request a free sample copy or view report summary: Glaucoma Surgery Devices Market Report

Glaucoma Surgery Devices Market Report Highlights

• By product, the traditional surgery devices segment dominated the market by capturing a share of over 40% in 2022 owing to the high preference for traditional glaucoma surgery

• Based on surgery method, the traditional glaucoma surgery segment held the largest market share of 35.11% in 2022 owing to its efficiency

• The ophthalmic clinics end-use segment is expected to expand at the fastest CAGR of 4.80% over the forecast period attributed to the rising number of patients suffering from ophthalmic and other related disorders

• North America held the largest share of 37.26% in 2022 and is expected to expand at a healthy CAGR over the forecast period

• Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to the presence of key players and the increasing prevalence of diabetes

Glaucoma Surgery Devices Market Segmentation

Grand View Research has segmented the global glaucoma surgery devices market on the basis of product, surgery method, end-use, and region:

Glaucoma Surgery Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Glaucoma Drainage Device

  • Valves

  • Glaucoma Drainage Implant

  • Glaucoma Tube Shunts

  • Stents

• Traditional Surgery Devices

  • Scalpel

  • Forceps

  • Ophthalmic Scissors

  • Punch

  • Sutures

  • Surgical Drapes

  • Microcatheter

  • Others

• Diamond Knives

• Laser Systems

• Others

Glaucoma Surgery Devices Surgery Method Outlook (Revenue, USD Million, 2018 - 2030)

• Traditional Glaucoma Surgery

  • Trabeculectomy

  • Tube Shunt Surgery

• Minimal Invasive Glaucoma Surgery

  • Trabecular Meshwork Bypass

  • Suprachoroidal Space Implants

  • Subconjunctival Space Implants

  • Schlemm’s Canal Implants

  • Gonioscopy-assisted Transluminal Trabeculectomy

  • Endocyclophotocoagulation

• Laser Surgery

  • Trabeculoplasty

  • Iridotomy

  • Cyclophotocoagulation

Glaucoma Surgery Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ophthalmic Clinics

• Others

Glaucoma Surgery Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Glaucoma Surgery Devices Market

• Alcon, Inc.

• Glaukos Corporation

• Johnson & Johnson Vision

• AbbVie Inc. (Allergan Plc.)

• ASICO, LLC

• Carl Zeiss Meditec AG

• Katalyst Surgical

• Lumenis Ltd.

• Ziemer Ophthalmic Systems AG

• Iridex Corporation

• Altomed